The FDA has approved a new automated breast ultrasound system (ABUS) from GE Healthcare (Chalfont, UK) that could help clinicians find more cancers in women with dense breast tissue. According to GE, the new Invenia ABUS has been shown to find 35.7% more cancers in women with dense breasts than mammograms alone.